(Tehran Ana)- Developed by Royan Institute, WhartoCell is an allogeneic, off-the-shelf cell-based therapeutic product derived from umbilical cord mesenchymal stem cells, with development spanning basic research, preclinical and clinical studies, manufacturing and regulatory processes.
(Tehran Ana)- Iran’s lung transplantation program is advancing through complex transplant procedures and the emerging clinical application of AI and precision medicine.
(Tehran Ana)- In a first-of-its-kind procedure, researchers injected mitochondria into the eyes of a patient with severe vision loss in an attempt to restore damaged cells and preserve remaining vision.
(Tehran Ana)- Two Iranian-made micro-CT systems are enabling high-resolution digital imaging of medical and industrial samples at the micrometer scale.
(Tehran Ana)- An Iranian knowledge-based company has developed a domestically manufactured kneader for high-precision mixing of polymers, nanomaterials and pharmaceutical compounds, offering a local alternative to imported systems.
(Tehran Ana)- Researchers have found that increasing levels of the naturally occurring brain protein SORLA can reduce toxic tau tangles, limit brain damage and help preserve memory-related neural connections in Alzheimer’s disease.
(Tehran Ana)- A new study suggests that changes in workplace performance and earnings may appear as early as 15 years before a diagnosis of young-onset dementia, offering potential indicators for earlier detection of the disease.
(Tehran Ana)- A new umbilical cord–derived stem cell therapy has been approved in Iran for the treatment of osteoarthritis, expanding the country's regenerative medicine capabilities.